loadpatents
name:-0.009768009185791
name:-0.0047149658203125
name:-0.00040888786315918
Mandl; Stefanie Patent Filings

Mandl; Stefanie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mandl; Stefanie.The latest application filed is for "combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagonist of an immune checkpoint inhibitor".

Company Profile
0.5.9
  • Mandl; Stefanie - San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor
App 20210205429 - Foy; Susan ;   et al.
2021-07-08
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor
App 20170266270 - FOY; SUSAN ;   et al.
2017-09-21
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of TIM-3
App 20170106065 - FOY; SUSAN ;   et al.
2017-04-20
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor
App 20160271239 - FOY; SUSAN ;   et al.
2016-09-22
Methods And Compositions For The Treatment Of Cancer
App 20150283220 - Mandl; Stefanie ;   et al.
2015-10-08
Use of MVA to treat prostate cancer
Grant 8,377,688 - Delcayre , et al. February 19, 2
2013-02-19
Methods for treating cancer with a recombinant MVA expressing HER-2
Grant 8,313,740 - Delcayre , et al. November 20, 2
2012-11-20
Methods For Treating Cancer With Mva
App 20110008294 - DELCAYRE; Alain ;   et al.
2011-01-13
Use Of Mva To Treat Prostate Cancer
App 20110008386 - DELCAYRE; Alain ;   et al.
2011-01-13
Use of MVA to treat prostate cancer
Grant 7,867,483 - Delcayre , et al. January 11, 2
2011-01-11
Methods for treating cancer with a recombinant MVA expressing HER-2
Grant 7,807,146 - Delcayre , et al. October 5, 2
2010-10-05
Use Of Mva To Treat Prostate Cancer
App 20090104225 - Delcayre; Alain ;   et al.
2009-04-23
Methods for treating cancer with MVA
App 20080213302 - Delcayre; Alain ;   et al.
2008-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed